CELL INTELLIGENCE · 肿瘤细胞治疗研究

TIL（肿瘤浸润淋巴细胞）与乳腺放疗：国际免疫肿瘤生物标志物工作组展望

Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.

乳腺癌管理的新策略：从治疗到长期缓解

Novel strategies in breast cancer management: From treatment to long-term remission.

TIL（肿瘤浸润淋巴细胞）治疗实体瘤：探戈需要两个人？

Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?

三阴性乳腺癌治疗的免疫治疗策略

Immunotherapy Approaches for the Treatment of Triple-Negative Breast Cancer.

乳腺癌中的淋巴细胞浸润：一个有前景的预后指标

Lymphocyte infiltration in breast cancer: A promising prognostic indicator.

TIL（肿瘤浸润淋巴细胞）输注治疗一例难治性三阴性乳腺癌患者

Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer.

该病例在所选治疗方式上具有独特性和特殊性，因为患者所患疾病极为难治。

使用己酮可可碱减少肿瘤浸润调节性 T 细胞：三阴性乳腺癌小鼠模型中的离体分析

Decrease of Tumor-infiltrating Regulatory T Cells Using Pentoxifylline: An Ex Vivo Analysis in Triple-negative Breast Cancer Mouse Model.